Format

Send to

Choose Destination
J Med Microbiol. 2008 Aug;57(Pt 8):1036-8. doi: 10.1099/jmm.0.2008/000588-0.

Daptomycin non-susceptible meticillin-resistant Staphylococcus aureus USA 300 isolate.

Author information

1
Department of Internal Medicine and Infectious Disease, University of Nebraska Medical Center, Omaha, USA.

Abstract

Daptomycin is a novel bactericidal agent active against Gram-positive pathogens including meticillin-resistant Staphylococcus aureus (MRSA). Our case is unique in the description of an MRSA USA 300 isolate that developed decreased susceptibility to daptomycin during daptomycin and vancomycin therapy. Directed sequencing detected a previously reported mutation in mprF, resulting in a T345A substitution, associated with non-susceptibility to daptomycin.

PMID:
18628509
DOI:
10.1099/jmm.0.2008/000588-0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Ingenta plc
Loading ...
Support Center